Antibody-drug conjugates FDA-approved for patients with ovary and cervical cancers can improve outcomes.
By BECKY GILLETTE
Michael Ulm, MD, a Gynecological Oncologis.... Read More
Chief Medical Officers Discuss Adjusting to a Changing Focus
Over the past two decades, the role of Chief Medical Officer has evolved far beyond one of being a hospital-based,.... Read More
Question Raised: Is Monitored Anesthesia Care Always Needed?
A suggestion from one of the nation's largest for-profit managed healthcare companies concerning the use of anesth.... Read More